Home/Database/Somatrogon
Growth HormoneClinical/Approved

Somatrogon

Recombinant human growth hormone fused to three copies of the C-terminal peptide of hCG beta

275 Amino Acids · MW: 47000 Da

Amino Acids

275

Molecular Weight

47000 Da

Half-life

28-45 hours

Research Score

4.3

Studies

25

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is Somatrogon?

Somatrogon is a long-acting GH fusion protein engineered for once-weekly administration. The C-terminal peptide extensions prolong circulation time while preserving growth hormone activity.

Key Benefits & Mechanisms

once-weekly dosing

growth velocity support

sustained gh signaling

improved adherence

Research Summary

Somatrogon has been evaluated in pediatric GH deficiency studies as a once-weekly replacement option. Data show maintained IGF-1 exposure and growth outcomes comparable to daily GH in study populations.